Banque Pictet & Cie’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,236
| Closed | -$207K | – | 378 |
|
2025
Q1 | $207K | Sell |
3,236
-40,750
| -93% | -$2.6M | ﹤0.01% | 368 |
|
2024
Q4 | $5.35M | Sell |
43,986
-4,059
| -8% | -$494K | 0.04% | 144 |
|
2024
Q3 | $6M | Buy |
48,045
+13,521
| +39% | +$1.69M | 0.05% | 133 |
|
2024
Q2 | $5.45M | Buy |
+34,524
| New | +$5.45M | 0.05% | 138 |
|
2023
Q3 | – | Sell |
-26,760
| Closed | -$3.06M | – | 508 |
|
2023
Q2 | $3.06M | Buy |
26,760
+22,028
| +466% | +$2.52M | 0.03% | 201 |
|
2023
Q1 | $652K | Sell |
4,732
-2,146
| -31% | -$296K | 0.01% | 429 |
|
2022
Q4 | $891K | Sell |
6,878
-36,372
| -84% | -$4.71M | 0.01% | 414 |
|
2022
Q3 | $4.78M | Buy |
43,250
+26,570
| +159% | +$2.94M | 0.05% | 182 |
|
2022
Q2 | $1.25K | Buy |
16,680
+2,062
| +14% | +$155 | 0.01% | 392 |
|
2022
Q1 | $1.14M | Buy |
+14,618
| New | +$1.14M | 0.01% | 424 |
|